BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21560455)

  • 1. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
    Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
    Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
    Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
    Krueger GR; Manak M; Bourgeois N; Ablashi DV; Salahuddin SZ; Josephs SS; Buchbinder A; Gallo RC; Berthold F; Tesch H
    Anticancer Res; 1989; 9(6):1457-76. PubMed ID: 2560617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic manifestations in patients with chronic hepatitis C virus infection.
    Ramos-Casals M; Font J
    Curr Opin Rheumatol; 2005 Jul; 17(4):447-55. PubMed ID: 15956842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative diseases of uncertain classification.
    Monteverde A; Pileri S
    Ann Ital Med Int; 1991; 6(1 Pt 2):162-70. PubMed ID: 1742152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders.
    Polliack A; Lugassy G
    Leukemia; 1992 Nov; 6 Suppl 4():152-4. PubMed ID: 1434818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
    Ghinoi A; Mascia MT; Puccini R; Ferri C
    G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies in autoimmune rheumatic diseases - a mini-review.
    Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
    Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
    Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
    Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviruses in autoimmune liver disease: genetic or environmental agents?
    Mason AL; Xu L; Guo L; Garry RF
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):289-97. PubMed ID: 10604234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
    Kojima M; Motoori T; Nakamura S
    Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.